4/A: Lifeloc Technologies Director Exercises Stock Options, Amends Previous Filing

Director Michael Kornelsen exercised stock options and amended a previous filing to correct the number of securities beneficially owned.

Summary

• On February 28, 2025, Michael Kornelsen, a director of Lifeloc Technologies, Inc., exercised stock options to acquire 1,000 shares of common stock at a price of $3.8 per share.
• The transaction was executed pursuant to Rule 10b5-1(c).
• Kornelsen also amended a previous Form 4 filing to correct the number of securities beneficially owned following the transaction.
• 27,500 shares are indirectly owned through EDCO Partners LLLP.
• The stock options were granted on March 1, 2020, under the issuer's 2013 Stock Option Plan and were fully vested at the time of grant.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing about stock option exercises and a correction of a previous filing. There's no indication of significant positive or negative news.

Positives

• The exercise of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The exercise of stock options has a minor dilutive effect on existing shareholders.

Key Dates

Keywords

Stock Options, Form 4, Director, Beneficial Ownership, Lifeloc Technologies, LCTC, Amendment